1. Barnard, R.C., Moolenaar, R.J., and Stevenson, D. E. (1989). Iarc and Hhs lists of carcinogens: Regulatory use based on misunderstanding of the scope and purpose of the lists.Reg. Toxicol. Pharmacol.9, 81–97.
2.
2. Zwickey, R.E., and Davis, K. J. (1959). Carcinogenicity screening. In: Editorial Committee, ed. Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. Baltimore: Association of Food and Drug Officials.
3.
3. Huff, J.E., Mcconnell, E.E., Haseman, J.K., Boorman, G.A., Eustis, S.L., Schwetz, B.A., Rao, G.N., Jameson, C.W., Hart, L.G., and Rall, D. P. (1988). Carcinogenesis studies: Results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program.Ann. N.Y. Acad. Sci.534, 1–30.
4.
4. Higginson, J. (1987). Everything is a carcinogen? Reg.Toxicol. Pharmacol.7, 89–95.
5.
5. Higginson, J. (1983). Developing concepts on environmental cancer: The role of geographical pathology.Exp. Mutagen.5, 929–940.
6.
6. Weisburger, J.H. (1985). Definition of a carcinogen as a potential human carcinogen risk.Jpn. J. Cancer76, 1244–1246.
7.
7. Ames, B.N. (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases.Science221, 1256–1264.
8.
8. Ames, B.N. (1984). Dietary carcinogens and anti-carcinogens.Clin. Toxicol.22, 291–301.
10. Miller, E.C., and Miller, J. A. (1979). Naturally occurring chemical carcinogens that may be present in foods. In: Neuberger, A. and Jukes, T.H., eds. Biochemistry of Nutrition I A, vol. 27. Baltimore: University Park Press, pp. 123–165
11.
11. Lai, D.Y., and Woo, Y.-T. (1987). Naturally occurring carcinogens: An overview.Environ. Carcinogen. Rev. (J. Environ. Sci. Health, part C)5, 121–173.
12.
12. Sugimura, T. (1986). Studies on environmental chemical carcinogenesis in Japan.Science233, 312–318.
13.
13. Furihata, C., and Matsushima, T. (1986). Mutagens and carcinogens in foods.Annu. Rev. Nutr.6, 67–94.
14.
14. Wakabayashi, K., Sato, S., and Sugimura, T. (1989). Mutagens, carcinogens and tumor promotors in food. In: Dayan, A.D. and Paine, M.J., eds. Advances in Applied Toxicology.London: Taylor & Francis, pp. 81–104
15.
15. Federal Register. Office Of Science & Technology Policy. (1984). Part Ii. Chemical Carcinogens: Notice of review of the science and its associated principles.Fed. Reg.49(100), 21593–21661.
16.
16. Federal Register. (1986). Chemical Carcinogens: A review of the science and its associated principles.Fed. Reg.50(50), 10372–10442.
17.
17. Shubik, P. (1984). Criteria for evidence of chemical carcinogenicity.Science225, 682–687.
18.
18. Macmahon, B. (1979). Strengths and limitations of epidemiology. In: Strengths and limitations of epidemiologyWashington, Dc: National Research Council, pp. 91–104
19.
19. U.S. Department Hew (1964). Smoking and health. Report of the Advisory Committee to the Surgeon General, Public Health Service. pp. 19-21.
20.
20. Hill, A.B. (1985). The environment and disease—association or causation.Proc. R. Soc. Med.58, 295–300.
21.
21. Metzger, B., Crouch, E., and Wilson, R. (1989). On the relationship between carcinogenicity and acute toxicity.Risk Anal.9, 169–177.
22.
22. Yerushalmy, J. (1966). On observing causality from observed associations. In: Ingefinger, Relman, and Finland, eds. Controversy in Internal Medicine.Philadelphia: W.B. Saunders, pp. 599–668
23.
23. Espeland. M.A., and Hui, S. L. (1987). A general approach to analyzing epidemiological data that contain misclassification errors.Biometrics43, 1001–1012.
24.
24. Lynch, C.F., Hoolson, R.F., Ogorman, T., and Cantor, K. P. (1989). Chlorinated drinking-water and bladder-cancer-effect of misclassification on risk estimates.Arch. Environ. Health44, 252–259.
25.
25. Feinstein, A.R. (1988). Scientific standards in epidemiologic studies of the menace of daily life.Science242, 1257–1263.
26.
26. Rosenblatt, M.B., Teng, P.K., and Kerpe, S. (1973). Diagnostic accuracy in cancer as determined by post mortem examination. In: Ariel, I. M., ed. Progress in Clinical Cancer.Orlando, Fl: Grune & Stratton, pp. 71–80
27.
27. Matanoski, G.M., and Elliott, E. A. (1981). Bladder cancer epidemiology.Epidemiol. Rev.3, 203–229.
28.
28. Augustine, A., Hebert, J.R., Kabat, G.C., and Wynder, E. L. (1988). Bladder cancer in relation to cigarette smoking.Cancer Res.48, 4405–4408.
29.
29. Craum, G.F. (1985). Epidemiologic studies of micropollutants in drinking water.Sci. Total Environ.47, 461–472.
30.
30. Morrison, As., Buring, J.E., Verhoek, W.G., Aoki, K., Leck, I., Ohno, Y., and Obata, K. (1982). Coffee drinking and cancer of the lower urinary tract.J. Natl Cancer Inst.68, 91–94.
31.
31. Bravo, M.P. (1987). Bladder cancer and the consumption of alcoholic beverages in Spain.Eur. J. Epidemiol.3, 365–369.
32.
32. Bravo, M.P., Del Rey Calero, J., and Conde, M. (1988). Bladder cancer and asbestos in Spain.Rev. Epidemiol. Sante Publique36, 10–14.
33.
33. Bravo, M.P. (1987). Silica and bladder cancer in males.Arch. Esp. Urol.40, 635–651.
34.
34. Stasik, M.J. (1988). Carcinomas of the urinary bladder in a 4-chloro-O-toluidine cohort.Ont. Arch. Occup. Environ. Health60, 21–24.
35.
35. Ward, E., Halperin, W., Thun, M., Grossman, H.B., Fink, B., Koss, L., Osorio, A.M., and Schulte, P. (1988). Bladder tumors in two young males occupationally exposed to 4,4'-methylenebis(2-chloroaniline).Am. J. Ind. Med.14, 267–272.
36.
36. Risch, H.A., Burch, J.D., Miller, A.B., and Hill, G. B. (1988). Occupational factors and the incidence of cancer of the bladder in Canada.Br. J. Ind. Med.45, 361–367.
37.
37. Bonassi, S., Merlo, F., Pearce, N., and Puntoni, R. (1989). Bladder-cancer and occupational exposure to polycyclic aromatic-hydrocarbons.Int. J. Cancer44, 648451.
38.
38. Gonzales, C.A., Riboli, E., and Lopezabe, G. (1988). Bladder cancer among workers in the textile industry.Results of a Spanish case control study. Am. J. Ind. Med.14, 673480.
39.
39. Bravo, M.P., Delrey-Calero, J., and Conde, M. (1987). Employment in the petrochemical industries and cancer of the bladder in males.Arch. Esp. Urol.40, 632–634.
40.
40. Armstrong. B., Tremblay, C., and Theriault, G. (1988). Compensating bladder cancer victims employed in aluminum reduction plants.J. Occup. Med.30, 771–775.
41.
41. Malker, H.S.R., Mclaughlin, J.K., Silverman, D.T., Ericsson. J.L., Stone, B.J., Weiner, J.A., Malker, B.K., and Blot, W. J. (1987). Occupational risks for bladder cancer among men in Sweden.Cancer Res.47, 6763–6766.
42.
42. Ames, B.N. (1989). Mutagenesis and carcinogenesis: Endogenous and exogenous factors.Environ. Molec. Mutagen.14 (S16), 66–77.
44. Gregory, A.R. (1988). Species comparisons in evaluating carcinogenicity in humans.Reg. Toxicol. Pharmacol.8, 160–190.
45.
45. Roe, F.J.C. (1989). What is wrong with the way we test chemicals for carcinogenic activity?. In: Dayan, A.D. and Paine, A.J., eds. Advances in Applied Toxicology.London: Taylor & Francis, pp. 1–17
46.
46. Sirover, M.A., and Loeb, L. A. (1976). Infidelity of Dna synthesis in vitro screening for potential metal mutagensor carcinogens.Science194, 1434–1436.
47.
47. Furst, A. (1981). Bioassay of metals for carcinogenesis: Whole animals.Environ. Health Perspect.40, 83–91.
48.
48. Theiss, J.C. (1982). Utility of injection site tumorigenicity in assessing the carcinogenic risk of chemical to man.Regul. Toxicol. Pharmacol.2, 213–222.
49.
49. Tomatis, L., Partensky, C., and Montesano, R. (1973). The predictive value of mouse liver tumour induction in carcinogenicity testing—a literature survey.Int. J. Cancer12, 1–20.
50.
50. Roe, F.J.C. (1987). Liver tumors in rodents: Extrapolation to man. In: Cornelius, C.E., Simpson, C.F., and Rico, A.G., eds. Advances in Vererinary Science. Comparative Medicine: Experimental and Comparative Toxicology.New York: Academic Press, pp. 45–67
51.
51. Maronpot, R.R., Haseman, J.K., Boorman, G.A., Eustis, S.E., Rao, G.N., and Huff, J. E. (1987). Liver lesions in B6C3Fl mice: The National Toxicology Program, Experience and Position.Arch. Toxicol.10, (Suppl.) 10–26.
52.
52. Perera, F., Brennan, T., and Fouts, J. R. (1989). Comment on the significance of positive carcinogenicity studies using gavage as the route of exposure.Environ. Health Perspect.79, 315–321.
53.
53. Furst, A. (1987). Metal interactions in carcinogenesis. In: Fishbein, L., Furst, A., and Mehlman, M.A. (eds.) Genotoxic and Carcinogenic Metals: Environmental and Occupational Occurrence and Exposure.Princeton: Princeton Scientific Publishers, pp. 279–293
54.
54. Goldberg, L. (1974). Carcinogenesis Testing of chemicals.Cleveland: Crc Press.
55.
55. Dayan, A.D., and Brimblecombe, R. W. (1978). Carcinogenicity Testing: Principles and Problems. Proc. Symp. R. Coll. Physicians London, December 2, 1977. Lancaster, England: Mtp Press, Ltd.
56.
56. National Cancer Institute (1976). Guidelines for carcinogen bioassay in small rodents. Ntis, Pb264 061.
58. Purchase, I.F.H. (1980). Procedures for screening chemicals for carcinogenicity.Br. J. Ind. Med.37, 1–10,
59.
59. Hamm Jr., T.E. (1985). Design of a long-term animal bioassay for carcinogenicity. In: Milman, H.A. and Weisburger, E.K., eds. Handbook of carcinogen Testing.Park Ridge, Nj: Noyes Publishers, pp. 252–267
60.
60. Salsburg, D. (1983). The lifetime feeding study in mice and rats—an examination of its validity as a bioassay for human carcinogens.Fund. Appl. Toxicol.3, 6347.
61.
61. Furst. A., and Schlauder, M. C. (1977). Inactivity of two noble metals as carcinogens.J. Environ. Pathol. Toxicol.1, 51–57.
62.
62. Haseman, J.K., Huff, J.E., Rao, G.N., and Eustis, S. L. (1989). Source of variability in rodent carcinogenicity studies.Fund. Appl. Toxicol.12, 793–804.
63.
63. Haseman, J.K. (1988). Do cage effects influence tumor incidence? An examination of laboratory animal carcinogenicity studies utilizing Fischer-344 rats.J. Appl. Toxicol.8, 267–274.
64.
64. Roe, F.J.C. (1987). The problem of pseudocarcinogenicity in rodent bioassays.Banbury Rep.25, 189–202.
65.
65. Roe, F.J.C. (1988). Toxicity testing: Some principles and some pitfalls in histopathological evaluation.Hum. Toxicol.7, 405–410.
66.
66. Iarc (1987). Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of Iarc Monographs Vols. 1-42. Suppl. #7. Geneva: Who.
67.
67. Williams, G.M., Reiss, B., and Weisburger, J. H. (1985). A comparison of the animal and human carcinogenicity of environmental, occupational and therapeutic chemicals. In: Flamm, W.G., and Lorentzen, R.J., eds. Mechanisms and Toxicity of Chemical Carcinogens and Mutagens.Princeton: Princeton Scientific Publishing Co., pp. 207–248
68.
68. Von Wittenau, M.S., and Estes, P. C. (1983). The redundancy of mouse carcinogenicity bioassays.Fund. Appl. Toxicol.3, 631–639.
69.
69. Gold, L.S., Bernstein, L., Magaw, R., and Slone, T. H. (1989). Interspecies extrapolation in carcinogenesis: Prediction between rats and mice.Environ. Health Perspect.81, 211–219.
70.
70. Haseman, J.K., and Huff, J. E. (1987). Species correlation in long-term carcinogenicity studies.Cancer Lett.37, 126–132.
71.
71. Di Carlo, F. J. (1984). Carcinogenesis bioassay data: Correlation by species and sex.Drug Metab. Rev.15, 409–413.
72.
72. Lawley, P.D. (1989). Mutagens as carcinogens: Development of current concepts.Mutat. Res.213, 3–25.
73.
73. Lijinsky, W. (1989). A view of the relation between carcinogenesis and mutagenesis.Environ. Molec. Mutagen.14 (S16), 78–84,
74.
74. Weisburger, J.H., and Williams, G. M. (1987). Testing procedures to define carcinogens as human cancer risks. In: Roloff, M.V. and Wilson, A.G.E., eds. Human Risk Assessment—The Role of Animal Selection and Extrapolation.London: Taylor & Francis, pp. 163–186
75.
75. Dybing, E. (1986). Predictability of human carcinogenicity from animal studies.Reg. Toxicol. Pharmacol.6, 399–415.
76.
76. Coulston, F., and Shubik, P. (1980). Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis.Norwood, Nj: Ablex Pub. Corp.
77.
77. Grasso, P. (1989). Epidemiology and experimental toxicology—Is there a meeting ground? Discussion paper.J. Roy. Soc. Med.82, 470–473.
78.
78. Hayes, J.R., and Campbell, T. C. (1980). Nutrition as a modifier of chemical carcinogenesis. In: Slaga, T. J., ed. Carcinogenesis. Modifiers of Chemical Carcinogenesis.New York: Raven Press, pp. 207–241
79.
79. Palmer, G. (1985). Diet, nutrition, and cancer.Hog. Food Nutr. Sci.9, 283–241.
80.
80. Williams, G.M., and Weisburger, J. H. (1986). Food and cancer: Cause and effect? Surg.Clin. North Am.66, 873–889.
81.
81. Wintrobe, M.M. (1952). Symposium on nutritional factors in cancer research.Tex. Reg. Biol. Med.10, 931–1098.
82.
82. Seemayer, T.A., and Cavenee, W. K. (1989). Biology of disease. Molecular mechanisms of oncogenesis.Lab. Invest.60, 585–599.
83.
83. Weinberg, R.A. (1988). Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.Cancer Res.49, 3713–3721.
84.
84. Yuspa, S.H., and Poirier, M. C. (1988). Chemical carcinogenesis—from animal-models to molecular-models in one decade.Adv. Cancer Res.50, 25–70.
85.
85. Pitot, H.C. (1989). Progression: The terminal stage in carcinogenesis.Jpn. J. Cancer Res. (Gann)80, 599–607.
86.
86. Weinstein, I.B. (1988). The origins of human cancer: Molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment.Cancer Res.48, 4135–4133.
87.
87. Bouck, N.P., and Benton, B. K. (1989). Loss of cancer suppressors, a driving force in carcinogenesis.Chem. Res. Toxicol.2, 1–11.
88.
88. Tomatis, L., Attio, A., Wilbourn, J., and Shuker, L. (1989). Human carcinogens so far identified.Jpn. J. Cancer Res. (Gann)80, 795–807.
89.
89. De Flora, S., and Ramel, C. (1988). Mechanisms of inhibitors of mutagenesis and carcinogenesis.Classification and overview. Mutat. Res.202, 285–306.
90.
90. Watanabe, P.G., Reitz, R.H., and Schumann, A. M. (1988). Mechanistic considerations in carcinogenic risk estimation.J. Toxicol. Clinique Exper.8, 11–19.
91.
91. Phillipson, L. (1988). Positive and negative control of carcinogenesis.Eur. J. Haematol.41, 304–316.
92.
92. Spandidos, D.A., and Anderson, M. L. (1989). Oncogenes and onco-suppressor genes—their involvement in cancer.J. Pathol.157, 1–10.
93.
93. Bos, J.L. (1989). ras-Oncogenes in human cancer: a review.Cancer Res.49, 4682–4689.
94.
94. Levine, E.G., King, R.A., and Bloomfield, C. D. (1989). The role of heredity in cancer.J. Clin. Oncol.7, 527–540.
95.
95. Knudson, J.R. (1989). Hereditary cancers: Clues to mechanisms of carcinogenesis.Br. J. Cancer59, 661–666.
96.
96. Wiseman, C. (1986). Genetics and cancer. In: Mc Kenna, R.J. and Murphy, G.P., eds. Fundamentals of Surgical Oncology.New York: Macmillan, pp. 6–74
97.
97. Rall, D.P., Hogan, M.D., Huff, J.E., Schwetz, B.A., and Tennant, R. W. (1987). Alternatives to using human experience in assessing health risks.Annu. Rev. Public Health8, 355–385.
98.
98. Higginson, J. (1989). Changing concepts in prevention. Chemtech 354-361.
99.
99. Perera, F.P. (1987). Molecular cancer epidemiology: Anew tool in cancer prevention.J. Natl. Cancer Inst.78, 887–898.
